A NATIONWIDE SURVEY OF ANTIBIOTIC PRESCRIBING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH BACTERIAL PNEUMONIA

被引:21
作者
GRASELA, TH
WELAGE, LS
WALAWANDER, CA
TIMM, EG
PELTER, MA
POIRIER, TI
WALTERS, JK
机构
[1] SUNY BUFFALO,SCH MED,BUFFALO,NY 14260
[2] SUNY BUFFALO,CTR PHARMACOEPIDEMIOL,BUFFALO,NY 14260
[3] UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109
[4] DUQUESNE UNIV,CLIN PHARM,PITTSBURGH,PA 15219
[5] MARY IMOGENE BASSETT HOSP,DEPT PHARM,COOPERSTOWN,NY
[6] HUMANA HOSP W HILLS,W HILLS,CA
[7] ST FRANCIS MED CTR,CLIN PHARM SERV,PITTSBURGH,PA
[8] FRANCIS SCOTT KEY MED CTR,DEPT PHARM SERV,BALTIMORE,MD
来源
DICP-THE ANNALS OF PHARMACOTHERAPY | 1990年 / 24卷 / 12期
关键词
D O I
10.1177/106002809002401215
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antibiotic prescribing information was prospectively collected on 1822 hospitalized patients treated for suspected or documented bacterial pneumonia. Antibacterial therapy with a single antibiotic was employed in more than 50 percent of the patients, with cefazolin, cefuroxime, ampicillin, and ceftriaxone sodium representing the most commonly employed agents. Combination therapy using two antibiotics was employed in approximately 30 percent of patients with the aminoglycosides, particularly gentamicin, used extensively. A satisfactory outcome was achieved in approximately 80 percent of patients with a community- or institutional-acquired pneumonia; only 66 percent of nosocomial pneumonias had a satisfactory outcome. An important observation was the apparently common practice of switching patients to an oral antibiotic regimen after an average of seven days of antibiotics and subsequently discharging the patient. No difference was observed in the patterns of clinical response or duration of therapy for culture-positive versus culture-negative patients. The results of this surveillance program can serve as a basis for comparison of institution-specific drug utilization evaluation programs.
引用
收藏
页码:1220 / 1225
页数:6
相关论文
共 12 条
  • [1] CONTE JE, 1988, MANUAL ANTIBIOTICS I, P125
  • [2] DONOWITZ GR, 1985, PRINCIPLES PRACTICES, P394
  • [3] GARB JL, 1978, JAMA-J AM MED ASSOC, V240, P2169
  • [4] A CLINICAL PHARMACY-ORIENTED DRUG SURVEILLANCE NETWORK .2. RESULTS OF A PILOT PROJECT
    GRASELA, TH
    EDWARDS, BA
    RAEBEL, MA
    SISCA, TS
    ZAROWITZ, BJ
    SCHENTAG, JJ
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (11): : 909 - 914
  • [5] A CLINICAL PHARMACY-ORIENTED DRUG SURVEILLANCE NETWORK .1. PROGRAM DESCRIPTION
    GRASELA, TH
    SCHENTAG, JJ
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (11): : 902 - 908
  • [6] HORAN T, 1988, ANTIMICROBIC NEWSLET
  • [7] Horan T C, 1986, MMWR CDC Surveill Summ, V35, p17SS
  • [8] GUIDELINES FOR IMPROVING THE USE OF ANTIMICROBIAL AGENTS IN HOSPITALS - A STATEMENT BY THE INFECTIOUS-DISEASES-SOCIETY-OF-AMERICA
    MARR, JJ
    MOFFET, HL
    KUNIN, CM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) : 869 - 876
  • [9] REED MD, 1989, PHARMACOTHERAPY PATH, P1089
  • [10] 1984, STAT ABSTR US